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Background: There is evidence suggesting that migraine may be associated with vertigo. The aim of this study
was to assess the risk of benign paroxysmal positional vertigo (BPPV), the most common form of vertigo, in patients
with migraine using a population-based dataset.
Methods: The National Health Insurance Research Database in Taiwan was searched for migraine patients and was
also used to select an age- and sex-matched cohort of subjects without migraine. The analyses included 8266 migraine
patients and 8266 controls. The incidence rates of BPPV in the two cohorts were compared. Cox proportional hazard
models were used to identify risk factors for BPPV in migraine patients.
Results: In the migraine cohort, 1.11 % of the patients developed BPPV compared to 0.5 % of the controls. The incidence
rate ratio was 2.03 (95 % CI 1.41–2.97; p <0.001). Cox proportional hazards analysis showed that age ≥40 years (HR 2.20;
95 % CI 1.40–3.45; p = 0.001), coronary artery disease (HR 4.62; 95 % CI 1.12–19.01; p = 0.034), and the number of
outpatient department visits to neurologists because of migraine (HR 2.93; 95 % CI 2.50–3.44; p >0.001) were
associated with an increased risk for BPPV.
Conclusion: The results showed that patients with migraine had a 2.03-fold increased risk of developing BPPV
compared with age- and sex-matched controls. Although BPPV may not be a common condition in migraine patients,
migraine sufferers with vestibular symptoms should alert physicians to the possibility of BPPV, particularly if patients are
aged ≥40 years, have a history of coronary artery disease, or have frequent visits to neurologists clinics because of migraine.
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Both migraine and vertigo rank among the most com-
mon complaints in the general population. Making an
association between migraine and dizziness dates back
to the 19th century when Liveing first mentioned their
connection [1]. Later, a Kayan and Hood reported that
migraine patients had a much higher incidence of
vertigo than the tension headache patients (26.5 %
versus 7.8 %) [2]. An epidemiological study had reported
that there might be a link between migraine and vertigo* Correspondence: sjwang@vghtpe.gov.tw
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provided the original work is properly credited[3]. In Taiwan, migraine has a prevalence ranging from
8 % to 15 % [4]. People between the ages of 25 and 55,
usually the most productive years of life, have the
highest prevalence of migraine [5].
A number of studies have reported findings which
suggesting that repeated migraine attacks can result in
progressive structural and functional alterations of the
brain [6]. Migraine also is a risk factor for ischemic
stroke and there are reports of ischemic stroke occurring
during migraine attacks [6, 7].
The prevalence of dizziness and vertigo in the general
population is approximately 20 % to 30 % [3]. Many
migraine patients suffered from dizziness or vertigo.
Benign paroxysmal positional vertigo (BPPV) is the most
frequent cause of vertigo [8]. It can be easily diagnosed
and usually rapidly corrected. Studies have reported thate distributed under the terms of the Creative Commons Attribution License
hich permits unrestricted use, distribution, and reproduction in any medium,
.
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population [8] with a life time prevalence of 2.4 %. The
prevalence is increased among elderly persons and
among women, with peak onset between 50 and 60 years
of age and a female-to-male ratio of 2:1 to 3:1 [9]. BPPV
is characterized by brief spinning sensations lasting less
than 1 min, which are generally induced by an abrupt
change in head position with respect to gravity. It is be-
lieved to be caused by otolith, i.e., small calcium carbon-
ate crystals that enter the semicircular canals from the
utricle, one of the otolith organs in the inner ear. A
change of the head position results in these crystals trav-
elling within the semicircular canals which drives move-
ment of the endolymph causing the sensation of vertigo
[8]. Clinically, BPPV can usually be diagnosed based
on the nystagmus induced by Dix-Hallpike maneuver
[8, 10] and can often be successfully treated immediately
using Epley’s canalith-repositioning maneuver [8].
Previous researches have shown that migraine and ves-
tibular dysfunction may have potential interactions and
relationships via several conditions including BPPV or
other disorders related to inner ear dysfunction [11, 12].
Therefore, the aim of this study was to explore the risk
of BPPV in migraine patients.Materials and methods
Data sources
Taiwan launched the National Health Insurance (NHI)
program in 1995 to finance health care for all citizens.
The NHI system now covers 99.9 % of Taiwan’s popula-
tion, and 93 % of the country’s hospitals and clinics are
NHI-contracted [13]. The NHI is a mandatory, single-
payer social insurance system, offering almost universal
medical care. It includes coverage for outpatient, in-
patient, emergency, dental, traditional Chinese medi-
cine services, and prescription drugs. In 1999, the
Bureau of National Health Insurance made patient data
available electronically through the National Health
Insurance Research Database (NHIRD) project. The
multiple NHI databases (i.e. NHI enrollment files,
claims data, and registry of drug prescriptions) provide
comprehensive utilization and enrollment information
for all patients under the NHI program. This study
used NHI databases that are managed and publicly re-
leased by the National Health Research Institute of
Taiwan. The confidentiality of the data abides by the
regulations of the Bureau of the NHI and the National
Health Research Institute. All information that would
potentially expose a specific individual to be identified
has been encrypted. Since the NHI dataset consists of
de-identified secondary data for research purposes, this
study was exempt from full review by the institutional
review board.Study population
A retrospective cohort study was conducted using a
dataset from January 1, 2000 to December 31, 2009.
Patients who were diagnosed with migraine by a neur-
ologist according to the migraine diagnosis codes
(346.0×, 346.1×, and 346.9×) in the International Clas-
sification of Diseases, Ninth Revision, Clinical Modifi-
cation (ICD-9-CM) were enrolled. Patients diagnosed
with migraine at an age < 20 or ≥ 65 years were ex-
cluded. Patients with antecedent BPPV (386.11) within
one year before the diagnosis of migraine were also
excluded. In addition, those diagnosed with acoustic
neuroma (225.1), Meniere’s disease (386.0×), vestibular
neuritis (386.12), labyrinthitis (386.3×), sudden hear-
ing loss (388.2), or head injury (310.2, 800.×-804.×,
850.×-854.×, 870.×-873.×, 907.0, 907.1, 959.0×, and
V15.52) at any time within the study period were also
excluded from the analysis. Subjects without migraine
were randomly selected from the same database for
the matched (non-exposure) cohort. Each migraine
patient was matched with one non-exposure subject
by age and sex within the same observational period.
Both the migraine cohort (n = 8,266) and the matched
cohort (n = 8,266) were followed up until the develop-
ment of BPPV, transfer out of the NHI program, death,
or the end of the year 2010.Outcome
The outcome variable of this study was new occur-
rence of BPPV, as defined by a compatible ICD-9-CM
code 386.11 that was coded by a neurologist or an
otorhinolaryngologist.Statistical analysis
Categorical variables were presented as counts and per-
centages, and the chi-square test was performed for
group comparisons. The incidence rates (per 100,000
person-years) with 95 % confidence intervals (CIs) and
incidence rate ratios (IRRs) of BPPV in both groups were
analyzed. The Kaplan-Meier method and the Cox pro-
portional hazard models were used to explore the associ-
ations between each possible confounding factor and
BPPV. Factors with p < 0.1 in univariate analyses were
then included in a multivariable model. Extraction and
computation of data were performed with the Perl pro-
gramming language (version 5.12.2). A Microsoft SQL
Server 2005 (Microsoft Corp., Redmond, WA, USA) was
used for data linkage, processing, and sampling. The
statistical analyses were carried out with IBM SPSS
statistical software version 19.0 for Windows (IBM
Corp., Armonk, New York, USA). Statistical significance
was defined as a p value less than 0.05.
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Demographic characteristics of the study population
During the 10-year study period, a total of 14,164 mi-
graine patients were diagnosed or had diagnoses con-
firmed by neurologists. After excluding patients with
aged < 20 (n = 1,255) or ≥ 65 years (n = 1,304), BPPV before
migraine diagnosis (n = 65), acoustic neuroma (n = 21),
Meniere’s disease (n = 789), vestibular neuritis (n = 372),
labyrinthitis (n = 38), sudden hearing loss (n = 35), and head
injury (n = 2,019) diagnosed at any time within the
study period, the final sample consisted of 8266 pa-
tients for the analyses.
The demographic characteristics of the migraine co-
hort and matched cohort are presented in Table 1. In
each cohort, the median age was 38 years and 72 % of
the cohort were females. Among the migraine patients,
8.93 % were diagnosed as having migraine with aura. No
significant differences were found between the migraine
cohort and matched cohort in comorbidities (Table 1).
The median follow-up duration was 6.24 years for the
matched cohort and 6.29 years for the migraine cohort.Table 1 Baseline characteristics of patients with migraine and
matched cohort
Characteristics Migraine cohort Matched cohort P value
n =8266 n =8266
No. % No. %
Median age, years
(interquartile range)
38 (29–48) 38 (29–48)
Age, years
<40 4408 53.3 4408 53.3 1.000
≥40 3858 46.7 3858 46.7
Sex
Female 5952 72.0 5952 72.0 1.000
Male 2314 28.0 2314 28.0
Comorbidities
Diabetes mellitus 811 9.8 810 9.8 0.979
Hypertension 1460 17.7 1460 17.7 1.000
Heart failure 159 1.9 152 1.8 0.689
COPD 1081 13.1 1079 13.1 0.963
Asthma 873 10.6 870 10.5 0.939
Chronic kidney disease 541 6.5 539 6.5 0.950
Coronary artery disease 35 0.4 29 0.4 0.452
Dyslipidemia 1429 17.3 1429 17.3 1.000
Cirrhosis 67 0.8 58 0.7 0.419
Autoimmune diseases 588 7.1 582 7.0 0.856
Cerebrovascular disease 876 10.6 869 10.5 0.859
Previous BPPV 69 0.8 58 0.7 0.327
Migraine with aura 738 8.93
Abbreviations: COPD chronic obstructive pulmonary disease, BPPV benign
paroxysmal positional vertigoComparisons of the incidence rates of BPPV between
migraine patients and the matched cohort
Comparisons of BPPV incidence rates between the
migraine patients and the matched control group are
presented in Table 2.
Ninety-two (1.11 %) patients in the migraine cohort
and 45 (0.5 %) subjects in the matched cohort devel-
oped BPPV (Fisher’s exact test, p < 0.001). The mi-
graine cohort had a greater risk of developing BPPV
than the matched cohort (IRR = 2.03; 95 % CI 1.41–
2.97, p < 0.001). Both the older (aged ≥ 40 years) and
the younger (age < 40 years) patients with migraine had
a higher incidence of BPPV than the matched controls
(26.8 vs. 14.6 per 100,000 person-years and 10.6 vs. 4.0
per 100,000 person-years, p = 0.004, respectively). The
female migraine subgroup had a higher IRR than the
male subgroup, and this reached statistical significance
in the female subgroup (19.7 versus 14.1 per 100,000
person-years, Fisher’s exact test, p < 0.001). Patients
diagnosed as having migraine without aura had a sig-
nificantly higher IRR compared with the matched con-
trols (IRR = 1.99, 95 % CI 1.35–2.97, p < 0.001). Only
10 of the 738 patients who had migraine with aura de-
veloped BPPV, and no significant difference in IRR was
found between the migraine patients and controls
(IRR = 2.48, 95 % CI 0.71–10.81, p = 0.123) (Table 2).
The cumulative incidence of BPPV in patients with
migraine was significantly higher than that in the
matched cohort (log rank, p < 0.001, Fig. 1).
Risks factors for BPPV in migraine patients
Univariate Cox regression analysis revealed a signifi-
cantly increased risk of BPPV in migraine patients with
the following characteristics: age ≥40 years, hyperten-
sion, chronic obstructive pulmonary disease (COPD),
coronary artery disease (CAD), cerebrovascular disease,
and number of outpatient department (OPD) visits to
see a neurologist for migraine (all p < 0.05). If the factors
in univariate analysis have a p-value ≤ 0.1, they were
included in multivariate analysis. The results of multi-
variable Cox proportional hazards analysis showed
there was a significantly higher hazard risk of devel-
oping BPPV in the migraine cohort associated with
age ≥40 years (HR = 2.2, p = 0.001), CAD (HR = 4.62,
p = 0.034), and the number of visits to neurologist’s
OPD for migraine (HR = 2.93, p < 0.001) (Table 3).
Discussion
This nationwide, population-based, cohort study dem-
onstrated that migraine was associated with an in-
creased risk of developing BPPV that was 2.03 times
higher than that of the matched controls. The incidence
rate was 18.1 per 100,000 person-years in the migraine
cohort in contrast to 8.9 in the matched control cohort.
Table 2 The risk of benign paroxysmal positional vertigo (BPPV) for patients with migraine and matched cohort
Characteristics Patients with migraine, n = 8266 Matched cohort, n = 8266 IRR (95 % CI) P value
BPPV No. Per 10,000 person-year BPPV No. Per 10,000 person-year
Total 92 18.1 45 8.9 2.03 (1.41–2.97) <0.001
Age
<40 29 10.6 11 4.0 2.63 (1.28–5.84) 0.004
≥40 63 26.8 34 14.6 1.84 (1.19–2.88) 0.004
Sex
Male 20 14.1 12 8.5 1.66 (0.77–3.72) 0.168
Female 72 19.7 33 9.1 2.17 (1.42–3.39) <0.001
Aura
With aura 10 24.2 4 9.8 2.48 (0.71–10.81) 0.123
Without aura 82 17.5 41 8.8 1.99 (1.35–2.97) <0.001
Abbreviations: IRR incidence rate ratio, CI confidence interval
Chi-square tests were used for the group comparisons
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associated with three factors: migraineurs aged ≥40 years
(HR =2.20), CAD (HR =4.62) as well as neurologists’ OPD
visit. To the best of our knowledge, this research is the
first population-based study to demonstrate that migraine
is associated with an increased risk for BPPV.
Comorbid conditions such as hypertension, coronary
artery disease, and cerebrovascular disease would be
expected to be more common in a non-migraine popula-
tion than in a non-migraine population, however, in this
study there were no significant differences in prevalence
of comorbid conditions between the migraine group and
non-migraine control group. The reason for this was
that not only were the patients in the migraine group
and control group perfectly matched for sex and age butFig. 1 Cumulative incidence of benign paroxysmal positional vertigo in miwe also tried to match the groups for comorbid condi-
tions (Table 1).
There is now considerable epidemiological evidence
linking migraine to vertigo as well as dizziness. Among
patients whose are diagnosed as having migraine, about
25 % also complain of having vertigo and about 30 %
complain of dizziness [14]. In studies of patients with
dizziness, it has been found that such patients have a
higher prevalence of migraine than would be expected
and in researches of patients with migraine it has been
found that such patients have an increased prevalence of
vertigo and dizziness [3]. A recent cross-sectional study
by Calhoun et al investigated the point prevalence of
dizziness or vertigo in patients with migraine [15]. They
found that patients who had migraine with aura had agraine and matched cohort
Table 3 Risk factors for benign paroxysmal positional vertigo in
patients with migraine
Univariate analysis Multivariable analysisa
Variables HR (95 % CI) P value HR (95 % CI) P value




























































Migraine with aura 1.38
(0.71–2.65)
0.340
Abbreviations: HR hazard ratio, CI confidence interval COPD chronic obstructive
pulmonary disease, BPPV benign paroxysmal positional vertigo
aAll factors with p < 0.1 in univariate analyses were selected for Cox
multivariable analysis
The reference groups for each variable were as follows: Age < 40 years, female,
without co-morbidities, without neurologist OPD visit, or without
aura, respectively
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(24.5 % versus 12.1 %) as patients with migraine with-
out aura and that the prevalence of dizziness or vertigo
was significantly associated increased age. They also re-
ported a significant relationship between severity of mi-
graine pain and increased complaints of vertigo.
Almost half of the migraineurs reported concomitant
dizziness or vertigo when migraine pain was present at
an intensity of 7 or greater (on a scale of 1–10). In our
study, age ≥40 years was noted to be a risk factor forBPPV in patients with migraine, and this finding was
also presented in our study. Warninghoff et al carried
out the first study to investigate systematically the co-
morbidities of vertiginous diseases [16]. In this survey
study of 131 participants with various kinds of vertigin-
ous diseases, no increased prevalence (9.4 %) of mi-
graine was found compared with an epidemiological
study of a 6-month prevalence 11.2 % for migraine. The
relatively small sample size may explain the finding. A
retrospective study of 476 patients with BPPV con-
ducted by Uneri revealed that migraine and motion
sickness were three times more common in patients
with BPPV than in the general population and a family
history of migraine (58.4 %) was also more common
[17]. Another research by Fararilli et al investigated 186
BPPV in patients with migraine [18]. They compared a
group of patients with BPPV and migraine with a group
of patients with BPPV but without migraine or other
type of headache. They found that mean age of BPPV
onset was earlier in the former group (39 versus
53 years) and highly recurrent BPPV occurred more
often in the former group (19.4 % versus 7.3 %). The
findings suggested that the clinical features of BPPV are
affected by migraine.
The major strength of this study was its population-based
design, which examined a representative cohort of 1 million
citizens covered under the NHI in Taiwan. The large sam-
ple size and long observation period offered enough power
to delineate the differences between the two study groups.
To achieve a high validity, the enrolled migraine patients
had to be diagnosed only by neurologists, and the outcome
variable, new onset BPPV, had to be coded by a neurologist
or an otorhinolaryngologist. Additionally, patients with cer-
tain common inner ear diseases such as Meniere’s disease,
acoustic neuroma, vestibular neuritis, labyrinthitis, and sud-
den hearing loss, and those who had head injury at any time
within the study period were excluded since BPPV might
be related or secondary to these disorders. The strict
inclusion and exclusion criteria minimized possible coding
deviations in this claims dataset.
No direct pathophysiological link between migraine
and BPPV has yet been established. Baloh in 1997 had
postulated that neuro-otological symptoms in migraine
patients may originate from vasospasm and/or a certain
ion channel disorder [1]. Ishiyama et al once hypothe-
sized that patients with migraine suffered recurrent
damage to the inner ear because of vasospasm or some
other mechanism, which predisposes them to episodes
of BPPV [19, 20]. Therefore it could be inferred that re-
petitive vasospasms or disturbance of vestibule-cochlear
microvasculature might play a role in inner ear insult,
resulting in damages of the epithelium in the vestibule,
causing dislodge of the otoconia from utricular macula
into semicircular canal, and thus give rise to BPPV.
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between migraine and various hearing problems that
had been largely reported [21, 22]. It should also be
noted that a neurogenic inflammation in the inner ear
in experimental migraine animal models has been re-
ported [23]. Such recurrent neurogenic inflammation
might accelerate degeneration of the otoliths organ. How-
ever it remains unclear what triggers this inflammation.
Various specific chemical mediators such as nitric
oxide, serotonin receptors, calcitonin gene-related pep-
tide, and prostanoids have been found to play a role in
the headache phase of a typical migraine attack. And in the
postdromal phase, in which some migraine symptoms per-
sist after the headache ends, is characterized by persistent
blood flow changes in certain regions of the brain [20]. In
our study, CAD was associated with an increased risk (HR
4.62) for BPPV in migraineurs. This finding could possibly
echo the assumption that vasospasm and the downstream
vascular events that take place intracranially as well as in
the inner ear may at least partially explain the relationship
between migraine and BPPV. Further investigations would
be needed to clarify the underlying causes for the link be-
tween migraine and BPPV.
Our study has a number of clinical implications. Physi-
cians must be more alert to vestibular complaints of mi-
graine patients, especially in those older than 40 years,
with CAD, or who seek frequent OPD help for migraine,
since they are more likely to develop BPPV. Early recog-
nition and prompt management of BPPV are important
in resolving patients’ discomforts. Finally, migraine his-
tory should be routinely inquired about in patients with
BPPV. Examining migraine history can be used to clarify
the etiology and to delineate whether BPPV develop-
ment in migraineurs could have a different clinical pat-
tern or prognosis.
The followings are limitations of this study. First, devi-
ations in coding of the claims data were inevitable. A
matched control cohort was used to offset the possible
coding errors and to minimize bias. The Bureau of the
NHI routinely and randomly samples a fixed percentage
of claims from every contracted medical institution, and
the accuracy of coding is audited by an independent
group of physicians [13, 24, 25]. Second, it is difficult to
explore the prognosis of BPPV, since the NHIR database
is an administrative database that lacks detailed clinical
data on the severity and outcome of BPPV. Third, the
small sample size of certain subgroups might have con-
tributed to failure in showing migraine as a significant
risk factor in the subgroup analyses. Fourth, a major
differential diagnosis is central positional vertigo due to
a lesion in the cerebellum and its connection to the ves-
tibular nuclei, and in addition, positional nystagmus can
sometimes be seen during vestibular migraine attacks.
However, in this study we tried to achieve high validityby obtaining coding from a neurologist or an otorhino-
laryngologist. Therefore, we believe this considerably im-
proved the quality of coding.
Conclusions
In conclusion, our study demonstrated that patients with
migraine had a 2.03-fold greater risk of developing BPPV
compared to the age- and sex-matched control cohort.
Although BPPV is a rare condition, vestibular symptoms
in migraine patients should still alert physicians to the
possibility of occurrence of BPPV, especially those who
are older than 40, have CAD, or who make frequent
OPD visits for migraine.
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